GRISELDA CHENG-AKWA: Open Payments
NPI 1417412065 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 24 payments from 12 companies in 2025. Trend: 2023 $628 · 2024 $530 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | 3 | $220 |
| Ferring Pharmaceuticals Inc. | 1 | $164 |
| Sumitomo Pharma America, Inc. | 3 | $95 |
| Endo USA, Inc. | 3 | $78 |
| Antares Pharma, Inc. | 4 | $66 |
| TOLMAR, INC. | 2 | $58 |
| Teleflex LLC | 2 | $47 |
| Verity Pharmaceuticals Inc. | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| PFIZER INC. | 1 | $24 |
Products named: PYLARIFY, ADSTILADRIN, GEMTESA, XIAFLEX, XYOSTED, ELIGARD, BARRIGEL, Trelstar.
Industry payments across KY — which companies pay providers there.
